Work

Supplementary Table 3 from Profiling Bortezomib Resistance Identifies Secondary Therapies in a Mouse Myeloma Model

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 67K, Full drug table of CMAP predictions corresponding to Figure 2.

DOI: 10.1158/1535-7163.22500924

Authors: Holly A.F. Stessman, Linda B. Baughn, Aaron Sarver, Tian Xia, Raamesh Deshpande, Aatif Mansoor, Susan A. Walsh, John J. Sunderland, Nathan G. Dolloff, Michael A. Linden, Fenghuang Zhan, Siegfried Janz, Chad L. Myers, Brian G. Van Ness

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4362608994

Cites: 1

Cited by:

Related to: 10